Menu Search
Equities

Assura PLC

75A:DUS

Assura PLC

Actions
  • Price (EUR)0.458
  • Today's Change0.00 / 0.00%
  • Shares traded15.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 18:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Assura plc is a United Kingdom-based diversified healthcare real estate investment trust. The Company is a specialist healthcare property investor and developer. The Company owns and procures primary care properties across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care, and community healthcare buildings, so the NHS has the places and spaces it needs to deliver more services, tests, and treatments in the community. It provides customers with spaces to deliver diagnostic, specialist treatment and mental health services. The Company owns and manages a portfolio of about 600 properties. The Company’s subsidiaries include Assura (SC1) Ltd, Assura (SC2) Ltd, Assura Aspire Ltd, Assura Aspire UK Ltd, Assura Development Hub Ltd, Assura Primary Care Properties Ltd, and Assura GHC Ltd, among others.

  • Revenue in GBP (TTM)164.40m
  • Net income in GBP66.10m
  • Incorporated2014
  • Employees71.00
  • Location
    Assura PLC3 Barrington RoadALTRINCHAM WA14 1GYUnited KingdomGBR
  • Phone+44 161 552 4506
  • Fax+44 192 523 4503
  • Websitehttps://www.assuraplc.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.